An FDA official recommended approving puberty blockers for youth with gender dysphoria while acknowledging that a study showed the drugs were associated with an “increased risk in depression and suicidality,” according to internal emails released by America First Legal.[#item_full_content]
Cop29 live: can the climate summit find a way to raise $1tn a year?
Read More[#item_full_content]